Cosmos Current Deferred Revenue from 2010 to 2026
| COSM Stock | USD 0.46 0.02 3.33% |
Current Deferred Revenue | First Reported 2013-06-30 | Previous Quarter -82.5 K | Current Value 648.2 K | Quarterly Volatility 592.9 K |
Check Cosmos Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cosmos Health's main balance sheet or income statement drivers, such as Interest Expense of 1.6 M, Selling General Administrative of 14.2 M or Other Operating Expenses of 84.5 M, as well as many indicators such as Price To Sales Ratio of 0.22, Dividend Yield of 0.38 or PTB Ratio of 0.49. Cosmos financial statements analysis is a perfect complement when working with Cosmos Health Valuation or Volatility modules.
Cosmos | Current Deferred Revenue | Build AI portfolio with Cosmos Stock |
Evaluating Cosmos Health's Current Deferred Revenue across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Cosmos Health's fundamental strength.
Latest Cosmos Health's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Cosmos Health over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Cosmos Health's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cosmos Health's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Cosmos Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 342,015 | |
| Geometric Mean | 43,409 | |
| Coefficient Of Variation | 234.00 | |
| Mean Deviation | 562,032 | |
| Median | 671.00 | |
| Standard Deviation | 800,314 | |
| Sample Variance | 640.5B | |
| Range | 3.1M | |
| R-Value | 0.03 | |
| Mean Square Error | 682.7B | |
| R-Squared | 0.0007 | |
| Significance | 0.92 | |
| Slope | 4,137 | |
| Total Sum of Squares | 10.2T |
Cosmos Current Deferred Revenue History
About Cosmos Health Financial Statements
Cosmos Health investors utilize fundamental indicators, such as Current Deferred Revenue, to predict how Cosmos Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | -145.9 K | -138.6 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Cosmos Health Correlation against competitors. To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Will Health Care Providers & Services sector continue expanding? Could Cosmos diversify its offerings? Factors like these will boost the valuation of Cosmos Health. Projected growth potential of Cosmos fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Cosmos Health data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.77) | Revenue Per Share | Quarterly Revenue Growth 0.379 | Return On Assets | Return On Equity |
Investors evaluate Cosmos Health using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Cosmos Health's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Cosmos Health's market price to deviate significantly from intrinsic value.
It's important to distinguish between Cosmos Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cosmos Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Cosmos Health's market price signifies the transaction level at which participants voluntarily complete trades.